Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple ...

Investing.com -- Celcuity Inc. (NASDAQ: CELC) stock rose 5.2% after the clinical-stage biotechnology company announced it will hold a conference call on Monday, July 28, 2025, to reveal topline ...

Pharmacists say insurance reimbursements fail to cover their costs. They say a new law isn’t enough to reverse the trend.

Senior living operators must be prepared to offer more than just higher wages if they hope to attract and retain workers in ...

On July 11, 2025, Kevin Feeley, Chief Financial Officer of GeneDx Holdings ( WGS -1.14%), reported the sale of 5,278 shares ...

A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but ...

St. Charles County Ambulance District proves that excellence in airway care starts with culture, not complexity — backed by ...

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...

The combined company will operate under the name 'ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol ...

Revenue cycle management leaders know that the battle for financial performance is increasingly being fought at the intersection of clinical accuracy and operational speed. As denials rise and margins ...

Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

Charta Health built an artificial-intelligence-powered platform to optimize medical billing and coding. The one-year-old ...